MediWound Ltd. — Regulatory Filings 2017

Sep 19, 2017

6-K 1 zk1720559.htm 6-K Licensed to: ZKG Document created using EDGARfilings PROfile 4.3.3.0 Copyright 1995 - 2017 Summit Financial Printing, LLC. All rights reserved.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 ____

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the month of September 2017

Commission File Number: 001-36349

MediWound Ltd. (Translation of registrant ’ s name into English)

42 Hayarkon Street

Yavne, 8122745 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

PROfilePageNumberReset%Num%2%%%

EXPLANATORY NOTE

Attached to this report as Exhibit 23.1 is the consent of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global.

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into MediWound Ltd.’s Registration Statement on Form F-3 filed with the Securities and Exchange Commission on January 25, 2016 (Registration No. 333-209106).

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Sharon Malka
Name: Sharon Malka
Title: Chief Financial and Operations Officer

3

EXHIBIT INDEX

The following exhibit is filed as part of this Form 6-K:

Exhibit	Description
23.1	Consent of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global.

4